Anxa11em1Lcu
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Anxa11em1Lcu |
| Name: |
annexin A11; endonuclease-mediated mutation 1, Liying Cui |
| MGI ID: |
MGI:8243872 |
| Synonyms: |
ANXA11-P36R |
| Gene: |
Anxa11 Location: Chr14:25842580-25887228 bp, + strand Genetic Position: Chr14, 15.06 cM
|
| Alliance: |
Anxa11em1Lcu page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology introduced a C-to-G change at position 104 (c.104C>G) resulting in a proline to arginine substitution at amino acid 35 (p.P35R) which corresponds to the human p.P36R, which is a hotspot mutation in amyotrophic lateral sclerosis patients. A synonymous mutation was also introduced by substituting the shadowed base T to disrupt PAM recognition and prevent further cleavage at the mutated site. mRNA expression level and protein levels in the cortex are comparable to wild-type mice in both heterozygotes and homozygotes.
(J:371245)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Anxa11 Mutation: |
74 strains or lines available
|
|
| Original: |
J:371245 Liu Q, et al., Gain-of-function ANXA11 mutation cause late-onset ALS with aberrant protein aggregation, neuroinflammation and autophagy impairment. Acta Neuropathol Commun. 2025 Jan 4;13(1):2 |
| All: |
1 reference(s) |
|